Study Evaluates Retatrutide for Liver Disease in Metabolic Dysfunction Patients | Retatrutide News

The SYNERGY-OUTCOMES study is investigating retatrutide and tirzepatide for preventing liver issues in metabolic dysfunction. This trial involves 4,500 ...
Clinical Trials · November 2, 2026